Evolution of the Average Target: Veradigm Inc.

Evolution of the Target Price: Veradigm Inc.

Changes in Analyst Recommendations: Veradigm Inc.

e341e4f710.qSN1_wxa_BNZ9F9WmpYWYd58qtZEvlSNtAuPwNMLWPI.-2Uirn03nmkDjTE_0aNEJ5RNnpsG8RrKwWbuhptpbYPidSWFRmmkcgaNOA~686e5b25e55b4eb78071ec12fecbccad
24-03-19 Deutsche Bank Downgrades Veradigm to Hold From Buy, Adjusts Price Target to $10 From $15 MT
24-01-19 RBC Halves Price Target on Veradigm to $11 From $22, Keeps Outperform Rating MT
24-01-03 Barclays Starts Allscripts Healthcare Solutions With Equalweight Rating, $11 Price Target MT
23-12-11 Deutsche Bank Adjusts Veradigm Price Target to $15 From $18, Maintains Buy Rating MT
23-07-06 Argus Research Downgrades Allscripts Healthcare Solutions to Hold From Buy MT
23-06-30 Deutsche Bank Adjusts Allscripts Healthcare Solutions Price Target to $18 From $21, Maintains Buy Rating MT
23-04-12 Stephens Initiates Allscripts Healthcare Solutions at Equalweight With $13 Price Target MT
23-02-01 Piper Sandler Downgrades Veradigm to Neutral From Overweight, Adjusts Price Target to $18.50 From $17 MT
22-11-18 JPMorgan Adjusts Price Target on Allscripts Healthcare Solutions to $20 From $19, Maintains Underweight Rating MT
22-11-09 Goldman Sachs Upgrades Allscripts Healthcare Solutions to Buy From Neutral, Adjusts Price Target to $23 From $22 MT
22-11-07 Deutsche Bank Adjusts Allscripts Healthcare Solutions Price Target to $21 From $20, Maintains Buy Rating MT
22-10-06 Deutsche Bank Adjusts Price Target on Allscripts Healthcare Solutions to $20 From $26, Maintains Buy Rating MT
22-09-16 KeyBanc Initiates Coverage on Allscripts Healthcare Solutions With Sector Weight Rating MT
22-07-12 Goldman Sachs Starts Allscripts Healthcare Solutions at Neutral With $21 Price Target MT
22-06-10 Piper Sandler Adjusts Price Target on Allscripts Healthcare Solutions to $17 From $19, Maintains Neutral Rating MT
22-03-18 Piper Sandler Adjusts Price Target on Allscripts Healthcare Solutions to $22 From $19, Maintains Neutral Rating MT
22-03-04 Deutsche Bank Lifts Allscripts Healthcare Solutions to Buy From Hold, Price Target to $26 From $20 MT
22-03-03 SVB Leerink Adjusts Allscripts Healthcare Solutions' Price Target to $24 from $22, Keeps Outperform Rating MT
22-01-25 SVB Leerink Upgrades Allscripts Healthcare Solutions to Outperform from Market Perform, Adjusts Price Target to $22 from $19 MT
22-01-25 Piper Sandler Adjusts Price Target on Allscripts Healthcare Solutions to $19 From $17, Maintains Neutral Rating MT
21-11-23 Deutsche Bank Adjusts Allscripts Healthcare Solutions PT to $20 From $18, Maintains Hold Rating MT
21-11-08 Canaccord Genuity Adjusts Price Target on Allscripts Healthcare Solutions to $21 From $18, Keeps Buy Rating MT
21-08-06 ALLSCRIPTS HEALTHCARE : RBC Lifts Price Target on Allscripts Healthcare Solutions to $19 From $17, Maintains Outperform Rating MT
21-05-20 ALLSCRIPTS HEALTHCARE : Deutsche Bank Adjusts Price Target on Allscripts Healthcare Solutions to $17 From $15, Maintains Hold Rating MT
21-03-02 ALLSCRIPTS HEALTHCARE : Argus Downgrades Allscripts Healthcare Solutions to Hold From Buy MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +30%
+32.77%
-10.4%
+17.14%
+20.48%
+53.94%
+46.16%
- +20.17%
- +46.02%
+81.48%
Average +33.78%
Weighted average by Cap. +21.94%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
5.000USD
Average target price
6.500USD
Spread / Average Target
+30.00%
High Price Target
8.000USD
Spread / Highest target
+60.00%
Low Price Target
5.000USD
Spread / Lowest Target
0.00%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Deutsche Bank Securities
RBC Capital Markets
Barclays
Argus
Stephens Inc.
Piper Sandler
JPMorgan Chase
Goldman Sachs
KeyBanc Capital Markets
SVB Leerink
Canaccord Genuity
UBS
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
5.000USD
Average target price
6.500USD
Spread / Average Target
+30.00%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MDRX Stock
  4. Consensus Veradigm Inc.